Reflections on the meningococcal group C infection immunisation campaign: views from the sharp end

M Lansley; H Bedford

doi:10.1016/s0264-410x(03)00160-9

Reflections on the meningococcal group C infection immunisation campaign: views from the sharp end

Vaccine. 2003 Jun 20;21(21-22):2877-81. doi: 10.1016/s0264-410x(03)00160-9.

Authors

M Lansley¹, H Bedford

Affiliation

¹ Children's Services, Skimped Hill Health Centre, Market Place, Bracknell, Berkshire RG12 1LH, UK. marilynlansley@aol.com

PMID: 12798630
DOI: 10.1016/s0264-410x(03)00160-9

Abstract

In July 1999, the Department of Health launched a campaign to immunise all children aged from 0-17 years with a new vaccine giving protection against meningococcal group C infection. Following the campaign, a survey of Immunisation Co-ordinators in England was conducted to identify strengths and weaknesses of the campaign. This paper summarises the main findings.

MeSH terms

Adolescent
Child
Child, Preschool
Humans
Immunization Programs*
Infant
Infant, Newborn
Meningococcal Infections / epidemiology
Meningococcal Infections / immunology
Meningococcal Infections / prevention & control*
Meningococcal Vaccines / immunology*
Neisseria meningitidis, Serogroup C / metabolism*
Parental Consent
Polysaccharides, Bacterial / administration & dosage*
Polysaccharides, Bacterial / immunology
Surveys and Questionnaires
United Kingdom / epidemiology

Substances

Meningococcal Vaccines
Polysaccharides, Bacterial
meningococcal group C polysaccharide